acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic]

RxCUI: 1088761
RxNorm name: acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic]
Term type: SBD
Status: Active
Updated: 2026-10-17 23:45:11

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 032011
Active start: 032011
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
acetaminophen	33.3 MG / 1 ML	acetaminophen	acetaminophen
phenyltoloxamine citrate	2 MG / 1 ML	phenyltoloxamine	phenyltoloxamine citrate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Solution	316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
acetaminophen	161
phenyltoloxamine	33408

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
RXNAV_STR	APAP 33.3 MG/ML / Phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic]	1	NAMES
RxNorm Name	acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic]	1	NAMES
RxNorm Synonym	2 linked values APAP 33.3 MG/ML / Phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic] Dologesic (APAP 500 MG / phenyltoloxamine citrate 30 MG) per 15 ML Oral Solution	2	NAMES
TTY	SBD	1	ATTRIBUTES
RxCUI	1088761	1	CODES
MMSL_CODE	BD27685	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
54859051206	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
738e7767-42de-4076-acf2-9152484c2007	DOLOGESIC 500 MG / 30 MG in 15 mL Oral Solution [PSN] · acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic] [SBD] · APAP 33.3 MG/ML / Phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic] [SY] · Dologesic (APAP 500 MG / phenyltoloxamine citrate 30 MG) per 15 ML Oral Solution [SY]	4	1	Drug Facts	20120619

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
02ddfc31-5d1e-4e55-af2a-5d87403b0796		National Council for Prescription Drug Programs	20120724
738e7767-42de-4076-acf2-9152484c2007	Drug Facts	Llorens Pharmaceutical International Division	20120619

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	N02BE	Anilides	ATC1-4		acetaminophen
MEDRT	D000082	Acetaminophen	CHEM	has_ingredient	acetaminophen
MEDRT	D001559	Benzhydryl Compounds	CHEM	has_ingredient	phenyltoloxamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	acetaminophen
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenyltoloxamine citrate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenyltoloxamine
MEDRT	D005334	Fever	DISEASE	may_prevent	acetaminophen
MEDRT	D005334	Fever	DISEASE	may_treat	acetaminophen
MEDRT	D005955	Glucosephosphate Dehydrogenase Deficiency	DISEASE	ci_with	acetaminophen
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	acetaminophen
MEDRT	D010146	Pain	DISEASE	may_prevent	acetaminophen
MEDRT	D010146	Pain	DISEASE	may_treat	acetaminophen
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	phenyltoloxamine citrate
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	phenyltoloxamine
MEDRT	D014581	Urticaria	DISEASE	may_treat	phenyltoloxamine citrate
MEDRT	D014581	Urticaria	DISEASE	may_treat	phenyltoloxamine
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	phenyltoloxamine citrate
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	phenyltoloxamine
MEDRT	N0000000108	Prostaglandin Receptor Antagonists	MOA	has_moa	acetaminophen
MEDRT	N0000175439	Analgesia	PE	has_pe	phenyltoloxamine
MEDRT	N0000175439	Analgesia	PE	has_pe	phenyltoloxamine citrate
MEDRT	N0000175724	Central Nervous System Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	phenyltoloxamine citrate
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	phenyltoloxamine
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	acetaminophen
MEDRT	N0000009072	Hypothalamic Endocrine Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000175725	Peripheral Nervous System Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	acetaminophen
MEDRT	N0000000042	Renal Excretion	PK	has_pk	acetaminophen

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Dologesic	rxnav_allrelated
DF	DF	Oral Solution	rxnav_allrelated
DFG	DFG	Oral Liquid Product	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
IN	IN	acetaminophen	rxnav_allrelated
IN	IN	phenyltoloxamine	rxnav_allrelated
MIN	MIN	acetaminophen / phenyltoloxamine	rxnav_allrelated
PIN	PIN	phenyltoloxamine citrate	rxnav_allrelated
SBD	SBD	acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution [Dologesic]	rxnav_allrelated
SBDC	SBDC	acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML [Dologesic]	rxnav_allrelated
SBDF	SBDF	acetaminophen / phenyltoloxamine Oral Solution [Dologesic]	rxnav_allrelated
SBDFP	SBDFP	acetaminophen / phenyltoloxamine citrate Oral Solution [Dologesic]	rxnav_allrelated
SBDG	SBDG	Dologesic Oral Liquid Product	rxnav_allrelated
SBDG	SBDG	Dologesic Oral Product	rxnav_allrelated
SCD	SCD	acetaminophen 33.3 MG/ML / phenyltoloxamine citrate 2 MG/ML Oral Solution	rxnav_allrelated
SCDC	SCDC	acetaminophen 33.3 MG/ML	rxnav_allrelated
SCDC	SCDC	phenyltoloxamine citrate 2 MG/ML	rxnav_allrelated
SCDF	SCDF	acetaminophen / phenyltoloxamine Oral Solution	rxnav_allrelated
SCDFP	SCDFP	acetaminophen / phenyltoloxamine citrate Oral Solution	rxnav_allrelated
SCDG	SCDG	acetaminophen / phenyltoloxamine Oral Liquid Product	rxnav_allrelated
SCDG	SCDG	acetaminophen / phenyltoloxamine Oral Product	rxnav_allrelated
SCDGP	SCDGP	acetaminophen / phenyltoloxamine citrate Oral Liquid Product	rxnav_allrelated
SCDGP	SCDGP	acetaminophen / phenyltoloxamine citrate Oral Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	SCHEDULE	0
NAMES	Prescribable Synonym	DOLOGESIC 500 MG / 30 MG in 15 mL Oral Solution
SOURCES	Source	Multum MediSource Lexicon